One of the most well-characterized gene targets of EWS-WT1 is PDGFA, whose role in DSRCT was first described by Haber and colleagues in 1997, just a few years after the identification of DSRCT as a distinct malignancy (23). This evidence concerns the gene PDGFA and desmoplastic small round cell tumor.